SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-21-071458
Filing Date
2021-03-05
Accepted
2021-03-05 16:07:27
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B4 d97958d424b4.htm 424B4 624046
2 GRAPHIC g97958g03h85.jpg GRAPHIC 26092
3 GRAPHIC g97958g05a02.jpg GRAPHIC 106996
4 GRAPHIC g97958g08h03.jpg GRAPHIC 134257
5 GRAPHIC g97958g62r70.jpg GRAPHIC 99574
  Complete submission text file 0001193125-21-071458.txt   1131146
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Filer) CIK: 0001549595 (see all company filings)

IRS No.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: 424B4 | Act: 33 | File No.: 333-253783 | Film No.: 21718551
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences